CIPROFLOXACIN\DEXAMETHASONE: 713 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
713
Total FAERS Reports
7 (1.0%)
Deaths Reported
43
Hospitalizations
713
As Primary/Secondary Suspect
9
Life-Threatening
39
Disabilities
Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE\DEXAMETHASONE ·
First Report: 1972 · Latest Report: 20250819
What Are the Most Common CIPROFLOXACIN\DEXAMETHASONE Side Effects?
#1 Most Reported
Drug ineffective
92 reports (12.9%)
#2 Most Reported
Ear pain
71 reports (10.0%)
#3 Most Reported
Ear infection
70 reports (9.8%)
All CIPROFLOXACIN\DEXAMETHASONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 92 | 12.9% | 1 | 6 |
| Ear pain | 71 | 10.0% | 0 | 3 |
| Ear infection | 70 | 9.8% | 0 | 1 |
| Ear discomfort | 49 | 6.9% | 0 | 1 |
| Pain | 37 | 5.2% | 0 | 0 |
| Febrile neutropenia | 36 | 5.1% | 0 | 3 |
| Incorrect route of drug administration | 31 | 4.4% | 0 | 0 |
| Hypoacusis | 30 | 4.2% | 0 | 2 |
| Hypersensitivity | 23 | 3.2% | 0 | 3 |
| Tinnitus | 23 | 3.2% | 0 | 0 |
| Headache | 22 | 3.1% | 0 | 5 |
| Dizziness | 21 | 3.0% | 0 | 0 |
| Ear swelling | 19 | 2.7% | 0 | 0 |
| Rash | 19 | 2.7% | 0 | 1 |
| Condition aggravated | 18 | 2.5% | 0 | 6 |
| No adverse event | 17 | 2.4% | 0 | 0 |
| Deafness | 16 | 2.2% | 0 | 0 |
| Drug hypersensitivity | 16 | 2.2% | 0 | 1 |
| Incorrect dose administered | 16 | 2.2% | 0 | 0 |
| Paraesthesia | 16 | 2.2% | 0 | 8 |
Who Reports CIPROFLOXACIN\DEXAMETHASONE Side Effects? Age & Gender Data
Gender: 56.6% female, 43.4% male. Average age: 44.3 years. Most reports from: US. View detailed demographics →
Is CIPROFLOXACIN\DEXAMETHASONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 0 |
| 2010 | 2 | 0 | 0 |
| 2011 | 2 | 0 | 0 |
| 2014 | 20 | 0 | 1 |
| 2015 | 23 | 1 | 1 |
| 2016 | 29 | 0 | 0 |
| 2017 | 19 | 0 | 1 |
| 2018 | 23 | 0 | 3 |
| 2019 | 24 | 0 | 10 |
| 2020 | 12 | 0 | 0 |
| 2021 | 6 | 0 | 1 |
| 2022 | 12 | 0 | 2 |
| 2023 | 5 | 0 | 0 |
| 2024 | 2 | 0 | 0 |
| 2025 | 10 | 0 | 1 |
What Is CIPROFLOXACIN\DEXAMETHASONE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 392 |
| Ear infection | 115 |
| Otitis externa | 55 |
| Otitis media acute | 30 |
| Ear pain | 13 |
| Postoperative care | 9 |
| Conjunctivitis | 7 |
| Psoriasis | 7 |
| Tympanic membrane perforation | 7 |
| Infection | 6 |
CIPROFLOXACIN\DEXAMETHASONE vs Alternatives: Which Is Safer?
CIPROFLOXACIN\DEXAMETHASONE vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE
CIPROFLOXACIN\DEXAMETHASONE vs CISAPRIDE
CIPROFLOXACIN\DEXAMETHASONE vs CISATRACURIUM
CIPROFLOXACIN\DEXAMETHASONE vs CISPLATIN
CIPROFLOXACIN\DEXAMETHASONE vs CISPLATIN\CYTARABINE\DEXAMETHASONE
CIPROFLOXACIN\DEXAMETHASONE vs CITALOPRAM
CIPROFLOXACIN\DEXAMETHASONE vs CITALOPRAM HYDROBROMIDE
CIPROFLOXACIN\DEXAMETHASONE vs CITALOPRAM\CITALOPRAM HYDROBROMIDE
CIPROFLOXACIN\DEXAMETHASONE vs CITICOLINE
CIPROFLOXACIN\DEXAMETHASONE vs CITRIC ACID
Official FDA Label for CIPROFLOXACIN\DEXAMETHASONE
Official prescribing information from the FDA-approved drug label.